Charles Schwab Investment Management Inc Boston Scientific Corp Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 7,892,374 shares of BSX stock, worth $608 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

7,892,374

Previous 7,694,726 2.57%

Holding current value

$608 Million

Previous $445 Million 21.52%

% of portfolio

0.13%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$57.6 - $68.62 $11.4 Million - $13.6 Million	197,648 Added 2.57%	7,892,374 $541 Million
Q4 2023 Feb 06, 2024	BUY	$48.64 - $57.81 $2.52 Million - $3 Million	51,892 Added 0.68%	7,694,726 $445 Million
Q3 2023 Nov 08, 2023	BUY	$50.19 - $54.68 $10.1 Million - $11 Million	201,008 Added 2.7%	7,642,834 $404 Million
Q2 2023 Aug 09, 2023	SELL	$49.72 - $54.64 $4,325 - $4,753	-87 Reduced -0.0%	7,441,826 $403 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $3.31 Million - $3.67 Million	-73,342 Reduced 0.98%	7,441,913 $372 Million

Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $5.83 Million - $6.96 Million	147,478 Added 2.0%	7,515,255 $348 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $14.6 Million - $43.6 Million	-397,617 Reduced 5.12%	7,367,777 $285 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $1.22 Million - $1.63 Million	-34,661 Reduced 0.44%	7,765,394 $289 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $10.1 Million - $11.1 Million	245,797 Added 3.25%	7,800,055 $345 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $7.4 Million - $8.72 Million	194,378 Added 2.64%	7,554,258 $321 Million
Q3 2021 Nov 16, 2021	BUY	$41.23 - $45.88 $29.2 Million - $32.5 Million	709,180 Added 10.66%	7,359,880 $319 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $6.39 Million - $7.33 Million	165,670 Added 2.55%	6,650,700 $284 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $16.4 Million - $18.5 Million	-465,971 Reduced 6.7%	6,485,030 $251 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $17.8 Million - $22.6 Million	537,768 Added 8.39%	6,951,001 $250 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $5.2 Million - $6.37 Million	150,843 Added 2.41%	6,413,233 $245 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $7.03 Million - $9.1 Million	232,804 Added 3.86%	6,262,390 $220 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $1.97 Million - $3.49 Million	76,349 Added 1.28%	6,029,586 $197 Million
Q4 2019 Feb 07, 2020	BUY	$37.87 - $45.37 $4.44 Million - $5.32 Million	117,260 Added 2.01%	5,953,237 $269 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $7.3 Million - $7.87 Million	181,062 Added 3.2%	5,835,977 $237 Million
Q2 2019 Aug 09, 2019	BUY	$34.91 - $42.98 $4.16 Million - $5.13 Million	119,294 Added 2.16%	5,654,915 $243 Million
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $2.67 Million - $3.31 Million	81,194 Added 1.49%	5,535,621 $212 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $4.15 Million - $5.11 Million	130,886 Added 2.46%	5,454,427 $193 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $1.31 Million - $1.54 Million	39,933 Added 0.76%	5,323,541 $205 Million
Q2 2018 Aug 08, 2018	BUY	$26.84 - $34.32 $3.44 Million - $4.4 Million	128,310 Added 2.49%	5,283,608 $173 Million
Q1 2018 May 07, 2018	BUY	$25.2 - $28.54 $6.2 Million - $7.03 Million	246,223 Added 5.02%	5,155,298 $141 Million
Q4 2017 Jan 17, 2018	BUY	$24.79 - $29.8 $4.65 Million - $5.6 Million	187,773 Added 3.98%	4,909,075 $122 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $124 Million - $138 Million	4,721,302	4,721,302 $138 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $110B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Boston Scientific Corp Transaction History